Androidal Fat Dominates in Predicting Cardiometabolic Risk in Postmenopausal Women
Table 1
Characteristics of participants at baselinea.
Quartile
Median
First
Third
Min
Max
Age (y)
224
54.33
52.06
56.79
45.84
65.04
TLMP (y)
224
2.76
1.76
5.02
0.79
10.02
Family History of CVD (n)
224
No
88
Yes
127
Don’t know
9
Weight (kg)
224
66.35
59.98
73.70
43.70
93.10
BMI (kg/m2)
224
24.46
22.33
27.03
17.84
31.66
Whole body fat mass (%)
224
34.4
30.45
38.36
18.12
45.95
Androidal fat mass (kg)
224
5.31
4.19
7.12
1.12
10.7
Serum total cholesterol (mg/dL)
224
206.5
189
226.2
142
297
Serum LDL-C (mg/dL)
224
127.5
109
141.2
62
192
Serum HDL-C (mg/dL)
224
64
55.75
76
30
111
Serum triacylglycerol (mg/dL)
224
76
59
98.25
18
290
Serum C-reactive protein (mg/L)
218
1.022
0.453
2.089
0.013
29.860
Plasma fibrinogen (mg/mL)
218
3.353
2.657
4.311
0.914
6.854
Plasma total homocysteine (μmol/L)
218
7.296
6.318
7.677
4.224
17.64
RBC folate (ng/mL)
217
10.45
8.896
12.82
4.595
40.13
Blood glucose (mg/dL)
224
85
80.75
90
57
117
Serum insulin (μU/mL)
218
11.39
8.437
13.96
0.104
36.14
HOMA
218
2.362
1.694
3.006
0.022
9.458
Serum uric acid (mg/dL)
224
4.15
3.5
4.8
1.3
9
Systolic BP (mm/Hg)
224
119.5
112.8
132
93
170
Diastolic BP (mm/Hg)
224
74.5
68
80
49
111
Resting heart rate (bpm)
224
68
63
74
44
99
Healthy Eating Index score
224
67
56
76
37
95
Baseline data are reported for the entire sample. Treatment groups did not differ significantly in any of the outcomes at baseline. The number of observations available at baseline Time since last menstrual period Assessed using dual-energy X-ray absorptiometery (DXA) Homeostatic model of insulin resistance
